Taking a Trip into Nature’s Medicine Cabinet: A Country Comparison of Efforts to Reschedule Psilocybin and MDMA for Therapeutic Use
No abstract is available for this record.
Bibliographic context
- Journal
- eYLS (Yale Law School)
- Date
- 2025-11-30
- Source
- OpenAlex
- DOI
- Unavailable
- PubMed
- Unavailable
Topics and keywords
Citation graph
0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.
Related papers
India’s Unique Legal Framework for Psilocybin Mushroom Research: An Unprecedented Opportunity in Psychiatric TherapeuticsIndian Journal of Psychological Medicine · 2026-02-04Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic ResearchPsychedelic Medicine · 2025-12-18Intentions, Spirituality, Set, and Setting Are Associated with Mystical Experiences in Psilocybin-Assisted TherapyPsychedelic Medicine · 2026-01-11Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 StudyPsychedelic Medicine · 2025-12-22Psilocybin reporting in media (PRiMe) for the treatment of depressionIrish Journal of Psychological Medicine · 2025-12-17Advancing treatment paradigms: the role of psilocybin in managing major depressive disorderAnnals of Medicine and Surgery · 2025-11-23Moral Considerations and the Experience of Ego Dissolution: Insights from PsilocybinAsian Journal of Ethics in Health and Medicine · 2024-12-31Psilocybin-Assisted Therapy May Enhance Conservation Values in Patients with Alcohol Use DisorderPsychedelic Medicine · 2024-11-24